HC Wainwright Forecasts Inventiva FY2026 Earnings

Inventiva S.A. Sponsored ADR (NASDAQ:IVA) – Research analysts at HC Wainwright issued their FY2026 EPS estimates for shares of Inventiva in a note issued to investors on Thursday, November 5th. HC Wainwright analyst A. Ghosh anticipates that the company will post earnings per share of ($0.59) for the year. HC Wainwright currently has a “Buy” rating and a $14.00 price objective on the stock. The consensus estimate for Inventiva’s current full-year earnings is ($0.75) per share. HC Wainwright also issued estimates for Inventiva’s FY2027 earnings at ($0.58) EPS, FY2028 earnings at ($0.50) EPS, FY2029 earnings at ($0.46) EPS and FY2030 earnings at ($0.09) EPS.

IVA has been the subject of a number of other reports. Guggenheim upped their price objective on shares of Inventiva from $11.00 to $14.00 and gave the stock a “buy” rating in a report on Tuesday, September 15th. Weiss Ratings upgraded Inventiva from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, October 23rd. Truist Financial raised their target price on Inventiva from $13.00 to $18.00 and gave the company a “buy” rating in a report on Friday, October 2nd. Wall Street Zen raised Inventiva from a “sell” rating to a “hold” rating in a research report on Saturday, October 3rd. Finally, Piper Sandler reiterated an “overweight” rating on shares of Inventiva in a research note on Wednesday, September 16th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $14.67.

Inventiva Stock Performance

Inventiva stock opened at $3.95 on Monday. The firm’s fifty day simple moving average is $3.69 and its 200-day simple moving average is $4.80. Inventiva has a 1-year low of $2.82 and a 1-year high of $7.29.

Inventiva (NASDAQ:IVA) last announced its quarterly earnings results on Friday, August 14th. The company reported ($0.14) EPS for the quarter. The company had revenue of $0.75 million during the quarter.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Platt Investment Counsel LLC bought a new stake in Inventiva during the third quarter valued at about $45,000. China Universal Asset Management Co. Ltd. increased its stake in shares of Inventiva by 78.7% in the third quarter. China Universal Asset Management Co. Ltd. now owns 38,600 shares of the company’s stock worth $142,000 after purchasing an additional 17,000 shares during the period. Engineers Gate Manager LP increased its stake in shares of Inventiva by 155.5% in the second quarter. Engineers Gate Manager LP now owns 71,116 shares of the company’s stock worth $269,000 after purchasing an additional 43,280 shares during the period. Commonwealth Equity Services LLC lifted its position in shares of Inventiva by 7.0% during the 3rd quarter. Commonwealth Equity Services LLC now owns 89,853 shares of the company’s stock worth $332,000 after purchasing an additional 5,857 shares during the last quarter. Finally, Seven Fleet Capital Management LP acquired a new position in shares of Inventiva during the 1st quarter worth about $1,111,000. Institutional investors and hedge funds own 19.06% of the company’s stock.

About Inventiva

Inventiva S.A. is a clinical-stage biopharmaceutical company headquartered in Daix, France. Founded in 2011, the company focuses on developing oral treatments for metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease associated with metabolic disorders. Inventiva’s lead drug candidate is lanifibranor, an investigational pan-peroxisome proliferator-activated receptor (pan-PPAR) agonist being evaluated in the Phase 3 NATiV3 clinical trial. The company expects topline trial results in Q4 2026 and, if results are positive, plans to pursue U.S. regulatory approval, with a potential commercial launch in 2028.